|
 |
AczoneThis page contains recent news articles, when available, and an overview of Aczone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....compared with the double that QLT hit two weeks ago when the Food and Drug Administration lifted some of the restrictions on its acne treatment Aczone. Motley Fool QLT reports 40 per cent decline Visudyne blindness treatment sales ... - Mar 3, 2008 In addition to Eligard, QLT USA also includes the company's Aczone acne drug which is nearing commercialization and its Atrigel drug delivery system. AOL Canada, Drug firm QLT up 24 per cent after company signals it's for sale - Mar 3, 2008 O'Connor pointed to growing revenue from Eligard, the potential of the company's acne treatment Aczone that could be launched as early as next summer and AOL Canada, QLT Announces 2007 Results - Feb 21, 2008 For the full year, expenditures for R and D in 2007 were $46.4 million, down from $56.4 million in 2006 primarily due to decreased spending on Aczone(TM) Lifescience-online, QLT Inc. plans to shed USA operations - Feb 15, 2008 The company's products include Eligard, a prostate cancer treatment; Aczone, a dermatology product for the treatment of acne; and Atrigel, a drug delivery Northern Colorado Business Report, QLT puts US operations on the block - Jan 18, 2008 The company hopes to get a good price for the US arm, especially if it gets a positive regulatory decision on the Aczone acne drug in March, Globe and Mail, Drugmaker QLT Cuts 115 Jobs in Restructuring (Update1) - Jan 18, 2008 The company announced two days ago it would sell its US company, which owns the prostate-cancer drug Eligard and the acne-treatment Aczone, and focus on Bloomberg QLT Restructuring, Cuts Senior Staff - Jan 18, 2008 ...in Vancouver and the QLT USA unit, which makes the prostate cancer treatment Eligard, the acne treatment Aczone and the drug delivery system Atrigel. Forbes, UPDATE 1-QLT to slash workforce by 45 percent, founder quits - Jan 18, 2008 Inc, whose primary assets include the Eligard product line for prostate cancer, Aczone, a dermatology product for the treatment of acne vulgaris, Reuters BC biotech pioneer QLT selling some assets - Jan 17, 2008 ...a move that includes its Eligard treatment for prostate cancer, Aczone, an acne treatment and its Atrigel drug delivery system. The news preceded dismal Canada.com, QLT Selling Assets, Cutting 115 Jobs - Jan 17, 2008 The unit sells the prostate cancer treatment Eligard, the acne treatment Aczone and the drug delivery system Atrigel. Also, there will likely be additional CNNMoney.com QLT to sell US division and lay off 115 staff as part of restructuring - Jan 16, 2008 The sale of QLT USA Inc. includes Eligard, along with acne treatment Aczone and the drug-delivery system Atrigel. QLT said plans to sell the US assets The Canadian Press Market Report -- Short Stories (QLTI) - Jan 24, 2008 The firm says in 2Q08 they expect the FDA will make a decision on the label revision for Aczone for acne. They expect that the FDA will remove the label MSN Money QLT reports 40 per cent decline Visudyne blindness treatment - Jan 17, 2008 In addition to Eligard, QLT USA also includes the company's Aczone acne drug which is nearing commercialization and its Atrigel drug delivery system. Canoe.ca, QLT founder Levy among those departing - Jan 18, 2008 Wednesday's restructuring announcement featured a decision to sell QLT's US business including its prostate cancer treatment Eligard and acne drug Aczone. ReportonBusiness.com, QLT selling US business, cutting jobs - Jan 17, 2008 The sale of QLT USA Inc., whose primary assets include the Eligard prostate cancer treatment; Aczone, an acne treatment; and the Atrigel drug delivery CBC News, QLTI: Restructuring to Include Sale of Assets and Workforce Reductions - Jan 17, 2008 These initiatives include the sale of QLT USA, Inc. whose primary assets include the Eligard(R) product line for prostate cancer, Aczone(TM), a dermatology Trading Markets (press release), QLT co-founder leaving company - Jan 19, 2008 Prospective buyers for QLT USA Inc. may delay bids until the US Food and Drug Administration makes a key ruling on acne treatment Aczone. Globe and Mail, Pfizer Updates CHANTIX Label In US To Include Warning To Patients ... - Jan 18, 2008 As part of the restructuring, the company will sell QLT USA, Inc. whose primary assets include the Eligard product line for prostate cancer, Aczone, RTT News, QLT Goes on the Block - Nov 29, 2007 QLT's other most visible asset is acne treatment Aczone, which the FDA approved in 2005. Aczone is unpartnered, and because of a very restrictive label, Motley Fool QLT assets expected to fetch a healthy premium - Nov 30, 2007 Although a sale will not likely happen until after the March, 2008 deadline for a US regulatory response on QLT’s acne drug Aczone, a bid may come in before National Post, QLT's promise to go on the block - Nov 29, 2007 The company sees potential for further sales from a pipeline of developing products that include its Aczone acne treatment and a specialized eye plug Financial Post, QLT investors get some relief - Nov 29, 2007 ...the prostate cancer treatment Eligard; and a new acne treatment called Aczone that could be ready for the market as early as the second quarter of next Globe and Mail, QLT assets worth $6 a share - Nov 28, 2007 ...or $9.25, adding that the “top end is unlikely� until the FDA removes a restrictive label on acne drug Aczone and QLT’s eye drug Visudyne turns around. Globe and Mail, Drug firm QLT up 23 per cent after company signals it's for sale - Nov 28, 2007 O'Connor pointed to growing revenue from Eligard, the potential of the company's acne treatment Aczone that could be launched as early as next summer and The Canadian Press Drug maker QLT mulls sale of all, part of assets - Nov 28, 2007 Although QLT is known for its Visudyne anti-blindness treatment, analysts see its Aczone acne formula attracting some interest among potential buyers. Reuters Canada, QLT shares up on formation of strategic committee; Merrill Lynch ... - Nov 28, 2007 That's when QLT's drug Aczone has its prescription drug user fee act date. A positive result from that, Merrill said, could allow QLT to launch the drug by CNNMoney.com QLT's move to auction block lifts shares - Nov 29, 2007 The company is also expecting a decision in March from the US Food and Drug Administration on its acne drug Aczone, which has had its commercial release Vancouver Sun, Emerging Markets Consulting, LLC.: Emerging Markets Consulting ... - Nov 29, 2007 ...a photosensitizer for the treatment of choroidal neovascularization; Eligard product line for prostate cancer; and Aczone, a dermatology product for the Trading Markets (press release), QLT Board authorizes exploration of strategic alternatives to ... - Nov 27, 2007 ...the outcome and timing of the FDA decision to remove the label restriction on Aczone is uncertain; general economic conditions and other factors, CNNMoney.com Acne associated with adolescence but also strikes adults - Nov 19, 2007 Aczone gel – not an antibiotic – is a newer topical drug for acne. You might not have tried it. How about the well-known other acne topicals: Retin-A, Truro Daily News, QLT Inc. swings to Q3 profit of US$346K, aims to cut costs 20 per cent - Oct 25, 2007 QLT is also hoping its acne treatment Aczone, a labelling change request to remove blood screening and monitoring requirements for which the US Food and The Canadian Press QLT Announces Q3 Results and Provides Guidance Update - Oct 25, 2007 If the revised labeling for Aczone is approved as we would hope, we could see revenue growth whether we out-license or retain Aczone(TM) following a CNNMoney.com The QT on QLT: Despite Apparent Problems Insiders Love This ... - Nov 1, 2007 Aczone is approved in the US and Canada, but it is not yet marketed. QLT recently agreed to purchase a company called forsight Newco II, InvestorIdeas.com (press release), Layoffs set for QLT - Oct 25, 2007 Aczone was approved in the US in 2005 and in Canada in 2006, but its commercial release has been held up by a FDA requirement that potential patients be Vancouver Sun, QLT in a Rut or Ready for a Comeback? - Oct 29, 2007 The rest of the QLT story remains the same; acne treatment Aczone has a March 23 FDA PDUFA target date for the possible label improvements that QLT is Motley Fool ACZONE - dapsone gel for acne treatment - 06 Sep 2007 QLT Inc. announced that it has received final approval from the US Food and Drug Administration (FDA) to market ACZONE (dapsone) Gel, 5% for the topical SpiritIndia, QLT announces FDA filing and review of Aczone(TM) labeling ... - Jul 22, 2007 CNNMoney.comAczone has the potential to be a key contributor to our growth if this label revision is ultimately approved by the FDA," said Bob Butchofsky, President and QLT Announces Q2 Results for 2007 - Jul 26, 2007 CNNMoney.com...from R&D expense in the second quarter last year primarily due to decreased spending on Aczone(TM), lemuteporfin and Atrigel(R) projects. QLT Announces Q1 Results for 2007 - Apr 25, 2007 PharmaLive.com (press release),...down $3.3 million from R&D expense in the first quarter last year primarily due to decreased spending on Aczone, lemuteporfin and Atrigel projects. New acne gel facing another FDA hurdle - Apr 22, 2007 News & Observer,The Canadian drug company that owns the rights to the gel, which is known as Aczone, has decided to delay its introduction. Clinical trials showed that some QLT Announces Q1 Results for 2007 - Apr 25, 2007 PharmaLive.com (press release),...down $3.3 million from R&D expense in the first quarter last year primarily due to decreased spending on Aczone, lemuteporfin and Atrigel projects. Market Report -- In Play (QLTI) - Dec 22, 2006 MSN MoneyThere will be an additional $1 mln payment if commercial orders for Aczone are produced in the Fort Collins plant. "In addition to increasing our QLT Inc. (QLTI) Completes Sales of QLT USA - Dec 22, 2006 StreetInsider.com (subscription),There will be an additional US$1 million payment if commercial orders for Aczone(TM) are produced in the Fort Collins plant. QLT Inc. sells US generic dermatology and manufacturing business ... - Dec 22, 2006 Canada.com,There will be an additional US$1-million payment if commercial orders for Aczone, a prescription medicine for acne patients who have certain blood disorders Market Report -- In Play (QLTI) - Dec 22, 2006 MSN MoneyThere will be an additional $1 mln payment if commercial orders for Aczone are produced in the Fort Collins plant. "In addition to increasing our QLT Inc. (QLTI) Completes Sales of QLT USA - Dec 22, 2006 StreetInsider.com (subscription),There will be an additional US$1 million payment if commercial orders for Aczone(TM) are produced in the Fort Collins plant. QLT Inc. sells US generic dermatology and manufacturing business ... - Dec 22, 2006 Canada.com,There will be an additional US$1-million payment if commercial orders for Aczone, a prescription medicine for acne patients who have certain blood disorders : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |